Post Herpetic Neuralgia: Clinical Trials

17 trials for Post Herpetic Neuralgia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 3 unknown, 2 recruiting, 1 terminated. 5 Not applicable, 4 Phase 3, 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Recruiting 1, Unknown 1
Phase 34Completed 3, Terminated 1
Phase 13Completed 2, Unknown 1
Phase 22Completed 2

Follow Post Herpetic Neuralgia: new trials by email Literature Review of Post Herpetic Neuralgia trials Research Report on Post Herpetic Neuralgia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block
Ultrasound, Fluoroscopy - Chronic Pain, Neuropathic Pain
Not applicableUnknownSeoul National University1182024-07-102024-05-29
Predictive Models for the Treatment of Recurrent Herpes Zoster Neuralgia Following Spinal Cord Electrical Stimulation.
Recurrence after undergo spinal cord stimulation - Post Herpetic Neuralgia
UnknownFeng Gao3002024-03-012024-05-13
The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index
Lumbar Sympathetic Ganglion Block - Chronic Pain, Complex Regional Pain Syndromes
Not applicableCompletedJeongsoo Kim402024-02-132024-07-11
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
SOMA pain manager smartphone application - Chronic Pain, Acute Pain
RecruitingBrown University8002023-06-202025-09-19
A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.
iN1011-N17 HCl Suspension (Part 1), iN1011-N17 HCl Capsule (Part 1), Placebo Capsule (Part 1) - Post Herpetic Neuralgia, Pain
Phase 1UnknowniN Therapeutics Co., Ltd.642022-11-112024-06-24
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
iN1011-N17, Placebo - Osteoarthritis, Pain
Phase 1CompletediN Therapeutics Co., Ltd.1042020-09-302024-06-21
Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain
Medtronic Summit RC+S or Percept RC - Spinal Cord Injuries, Nerve Injury
Not applicableRecruitingUniversity of California, San Francisco122019-10-242026-07-31
Acupuncture as Treatment of Post-herpetic Neuralgia: A RCT A Double-blinded Randomized Clinical Trial.
Superficial dry needling / Acupunture - Post Herpetic Neuralgia
Not applicableCompletedOdense University Hospital402019-09-192020-09-16
Treatment of Chronic Postherpetic Pain With Fat Grafting
Fat grafting - Post Herpetic Neuralgia, Herpes Zoster
Not applicableCompletedOdense University Hospital102018-05-012021-02-09
Titration Study of ABX-1431
ABX-1431, Placebo oral capsule - Post Herpetic Neuralgia, Diabetic Peripheral Neuropathy
Phase 1CompletedAbide Therapeutics392017-10-022019-07-12
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
NXN-462, Placebo - Post Herpetic Neuralgia
Phase 2CompletedNeurAxon Inc.1882013-01-012014-06-19
Phase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia
Post Herpetic Neuralgia
CompletedDepomed2012011-09-012013-03-21
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
Pregabalin, placebo - Post Herpetic Neuralgia
Phase 3CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.8062011-03-012021-01-28
Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia
Eslicarbazepine acetate (BIA 2-093), Placebo - Post Herpetic Neuralgia
Phase 3TerminatedBial - Portela C S.A.2402010-09-012014-04-07
A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)
EpiCept-NP-1 Cream, Gabapentin Capsules, placebo - Post Herpetic Neuralgia, PHN
Phase 2CompletedEpiCept Corporation3602007-07-012011-07-27
A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
Lidocaine 5% medicated plaster - Post Herpetic Neuralgia
Phase 3CompletedGrünenthal GmbH2592003-07-162023-09-13
A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)
Lidocaine 5% medicated Plaster, Placebo Plaster - Post Herpetic Neuralgia
Phase 3CompletedGrünenthal GmbH2652003-04-292023-09-13

Narrower conditions

Neuralgia, Postherpetic (17)  ·  Chronic Pain (7)  ·  Herpes Zoster (6)  ·  Neuralgia (6)  ·  Pain (4)  ·  Pain, Postoperative (4)  ·  Complex Regional Pain Syndromes (3)  ·  Osteoarthritis (2)  ·  Acute Pain (1)  ·  Arthritis (1)  ·  Cystitis, Interstitial (1)  ·  Diabetic Neuropathies (1)  ·  Failed Back Surgery Syndrome (1)  ·  Fibromyalgia (1)  ·  Irritable Bowel Syndrome (1)

Broader conditions

Nervous System Diseases (17)  ·  Neurologic Manifestations (17)  ·  Neuromuscular Diseases (17)  ·  Pathological Conditions, Signs and Symptoms (17)  ·  Signs and Symptoms (17)  ·  Peripheral Nervous System Diseases (16)  ·  Pain (13)  ·  Neuralgia (11)  ·  DNA Virus Infections (6)  ·  Herpesviridae Infections (6)  ·  Infections (6)  ·  Varicella Zoster Virus Infection (6)  ·  Virus Diseases (6)  ·  Pathologic Processes (4)  ·  Postoperative Complications (4)

Interventions

Lidocaine (2)  ·  Lidoderm (2)  ·  ABX-1431 (1)  ·  Fluoroscopy (1)  ·  Gabapentin (1)  ·  Pregabalin (1)  ·  Ultrasonography (1)  ·  eslicarbazepine acetate (1)

Sponsors

Grünenthal GmbH (2)  ·  Odense University Hospital (2)  ·  iN Therapeutics Co., Ltd. (2)  ·  Abide Therapeutics (1)  ·  Bial - Portela C S.A. (1)  ·  Brown University (1)  ·  Depomed (1)  ·  EpiCept Corporation (1)  ·  Feng Gao (1)  ·  Jeongsoo Kim (1)  ·  NeurAxon Inc. (1)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)  ·  Seoul National University (1)  ·  University of California, San Francisco (1)

Countries

United States (5)  ·  Denmark (3)  ·  Australia (2)  ·  Germany (2)  ·  India (2)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Colombia (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Hong Kong (1)  ·  Moldova (1)  ·  Poland (1)  ·  Russia (1)

Top investigators

Edward Chang, M.D. (1)  ·  Frederike H Petzschner, PhD (1)  ·  Jee Youn Moon, MD, PhD (1)  ·  Jeongsoo Kim, MD (1)  ·  Philip Starr, M.D., Ph.D. (1)  ·  Prasad Shirvalkar, M.D., Ph.D (1)  ·  Rekha Sathyanarayana (1)  ·  Robert H Dworkin, Ph.D. (1)  ·  Thomas Lategan, D.Phil. (1)  ·  Vitale Lisnic, PhD (1)

Results publications

PMID 19366301, PMID 19432499, PMID 22769236, PMID 27037091, PMID 27753650, PMID 31656630, PMID 32917571

NIH funding

2009 (1), UH3NS115631 (1)